combined CAS and CABG (2.4%), with an OR of 1.62
(95% CI, 1.1-2.5).278
If a sequential strategy is planned, CABG may need to
be deferred for 2 to 4 weeks because of the need for
dual-antiplatelet therapy after CAS. This has resulted in

Ricotta et al e23

some logistical difficulties in patients who require urgent
